Publicaciones en las que colabora con José Luis Labandeira-García (10)

2023

  1. Boolean analysis shows a high proportion of dopamine D2 receptors interacting with adenosine A2A receptors in striatal medium spiny neurons of mouse and non-human primate models of Parkinson's disease

    Neurobiology of Disease, Vol. 188

  2. Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates

    Brain : a journal of neurology, Vol. 146, Núm. 12, pp. 5000-5014

2021

  1. Glucocerebrosidase gene therapy induces alpha-synuclein clearance and neuroprotection of midbrain dopaminergic neurons in mice and macaques

    International Journal of Molecular Sciences, Vol. 22, Núm. 9

2018

  1. Gene therapy approaches in the non-human primate model of Parkinson’s disease

    Journal of Neural Transmission, Vol. 125, Núm. 3, pp. 575-589

  2. Glucocerebrosidase expression patterns in the non-human primate brain

    Brain Structure and Function, Vol. 223, Núm. 1, pp. 343-355

2017

  1. Neurochemical evidence supporting dopamine D1–D2 receptor heteromers in the striatum of the long-tailed macaque: changes following dopaminergic manipulation

    Brain Structure and Function, Vol. 222, Núm. 4, pp. 1767-1784

2015

  1. Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism

    Brain Structure and Function, Vol. 220, Núm. 5, pp. 2721-2738

  2. Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia

    Molecular Neurobiology, Vol. 52, Núm. 3, pp. 1408-1420

2012

  1. Unmasking adenosine 2A receptors (A2ARs) in monkey basal ganglia output neurons using cholera toxin subunit B (CTB)

    Neurobiology of Disease, Vol. 47, Núm. 3, pp. 347-357

2011

  1. Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis

    Journal of Psychopharmacology, Vol. 25, Núm. 1, pp. 97-104